Material Insights · Understanding the Material World

Small-molecule APIs: Trading

How India set price floors against cheap Chinese antibiotics

What this tab covers How it is bought and sold: buyers and sellers, price benchmarks and who publishes them, exchanges, contract types, traders, how Indian buyers price it, recent price points, and good sources to follow.

Who buys, and where

  • China (KSMs, fermentation APIs, commodity APIs)
  • India (regulated-market generic APIs)
  • Europe (complex and controlled APIs)

Who sells, and from where

  • US and EU generic formulators
  • India's domestic formulators
  • Africa, Latin America and global health tenders

Price benchmarks

BenchmarkPublisherBasis
Pharmaoffer API transaction averagesPharmaoffer12-month and 90-day averages from shipment records
IMARC and ChemAnalyst quarterly API price reportsIMARC, ChemAnalystassessed, quarterly

Contract types

  • Annual or multi-year supply agreements tied to DMF references
  • Spot purchase orders for generics
  • Long-term supply agreements for innovators (Divi's had three in validation in Q4 FY26)

Traders and distributors

  • Not dominated by traders; sourcing agents and distributors handle small buyers

How Indian buyers price it

  • Import parity from China (CIF plus customs duty)
  • Minimum import prices on penicillin G, 6-APA, amoxicillin (DGFT, Jan 2026, one year)
  • Finished drug ceiling prices set by NPPA under DPCO 2013, which caps how much API cost formulators can pass on

Recent price points

DatePriceBasisSource
Q2 2025$2,958/t paracetamolIndiaIMARC (2025)
Jan 2026Rs 2,216/kg penicillin G potassium (MIP)CIF India floorMedical Dialogues (Jan 2026)

Good sources to follow

Pharmaoffer API price and transactionsfreemium research site · Pharmaoffer

API transaction prices and trade flows by molecule

DCAT Value Chain Insightsfree newsletter · Drug, Chemical and Associated Technologies Association

API and CDMO industry news and analysis

Indian Pharma Postfree newsletter · Indian Pharma Post

Indian API and pharma company results

BioSpectrum Indiafree newsletter · MM Activ

Indian pharma and API self-reliance coverage